165 related articles for article (PubMed ID: 2692830)
1. Oncogenes, growth, and the cell cycle: an overview.
Studzinski GP
Cell Tissue Kinet; 1989 Nov; 22(6):405-24. PubMed ID: 2692830
[TBL] [Abstract][Full Text] [Related]
2. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
Yaar M; Peacocke M; Cohen MS; Gilchrest BA
J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
6. [Different regulation systems of cell cycle events (dysregulation of these events in the tumoral cell)].
Colomb E; Martin PM
Bull Cancer; 1991 Jan; 78(1):1-21. PubMed ID: 2021683
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes with potential nuclear function: myc, myb and fos.
Eisenman RN; Thompson CB
Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
[TBL] [Abstract][Full Text] [Related]
8. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone regulation of nuclear proto-oncogenes.
Schuchard M; Landers JP; Sandhu NP; Spelsberg TC
Endocr Rev; 1993 Dec; 14(6):659-69. PubMed ID: 8119231
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.
Campisi J; Gray HE; Pardee AB; Dean M; Sonenshein GE
Cell; 1984 Feb; 36(2):241-7. PubMed ID: 6692471
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
13. Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression.
Doppler W; Jaggi R; Groner B
Gene; 1987; 54(1):147-53. PubMed ID: 3038697
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes, protooncogenes, and signal transduction: toward a unified theory?
Storms RW; Bose HR
Adv Virus Res; 1989; 37():1-34. PubMed ID: 2690595
[TBL] [Abstract][Full Text] [Related]
15. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
16. Sulfur dioxide and benzo(a)pyrene modulates CYP1A and tumor-related gene expression in rat liver.
Qin G; Meng Z
Environ Toxicol; 2010 Apr; 25(2):169-79. PubMed ID: 19408242
[TBL] [Abstract][Full Text] [Related]
17. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
18. Regulation of bovine bronchial epithelial cell proliferation and proto-oncogene expression by growth factors.
Takizawa H; Beckmann JD; Yoshida M; Romberger D; Rennard SI
Am J Respir Cell Mol Biol; 1991 Dec; 5(6):548-55. PubMed ID: 1958382
[TBL] [Abstract][Full Text] [Related]
19. Transient inhibition of protein synthesis induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle.
Rosenwald IB; Setkov NA; Kazakov VN; Chen JJ; Ryazanov AG; London IM; Epifanova OI
Cell Prolif; 1995 Dec; 28(12):631-44. PubMed ID: 8634371
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer.
Minna JD; Battey JF; Brooks BJ; Cuttitta F; Gazdar AF; Johnson BE; Ihde DC; Lebacq-Verheyden AM; Mulshine J; Nau MM
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():843-53. PubMed ID: 3472765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
